Global Chemiluminescence Immunoassay Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, And Growth Forecast To 2029

                                          
Global Chemiluminescence Immunoassay Market 2021: By Product Type (Instruments, Automated, Semi-automated, Consumables, Software & Services), By Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease, Autoimmune Disease, Others), By End-User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Others)

Global Chemiluminescence Immunoassay Market is the title of an upcoming report offered by Trusted Business Insights. The report contains information and data, and inputs from both primary and secondary data sources, that have been verified and validated by experts in the target market. The report presents a thorough study of revenues, historical data, and information, key developments, and strategies by major players that offer vital insights and perspectives in to various scenarios market. Besides critical data and related information, the report includes key trends (both present and future), factors that are driving market growth, factors that are or could be potential restraints to market growth, as well as opportunities that can be leveraged for potential revenue generation in untapped regions and countries. It also covers threats or challenges for existing as well as new entrants in the market. The global chemiluminescence immunoassay market has been segmented on the basis of product, application, end-use, as well as regions and countries.Request Covid - 19 Impact

The Global Chemiluminescence Immunoassay market size was valued at USD $6.02 Billion in 2020, USD $6.43 Billion in 2021, forecasted to reach  USD $6.86 Billion in 2022, and is projected to reach USD $11.71 Billion by 2030, and is anticipated to expand at a CAGR of 6.7% over the forecast period from 2020 to 2030.

Overview:

Chemiluminescence immunoassay is a variation of the standard Enzyme Immunoassay (EIA), which is a biochemical technique used in immunology. They can also be used as diagnosis tools in medicine, as well as being used in several other industries for a wide range of applications.

Dynamics:

As chemiluminescence immunoassays are widely used to detect the presence of chronic diseases such as autoimmune diseases, cardiovascular diseases, cancer, obesity, diabetes, infectious diseases, etc., among individuals, the gradual increase in the prevalence of these chronic diseases across the world, as well as the introduction of technologically innovative advanced Chemiluminescence Immunoassays (CLIA) are some of the primary factors that are expected to continue to fuel the revenue growth of the global chemiluminescence immunoassays market over the next decade.
Moreover, chemiluminescence immunoassays are used by numerous research institutes and pharmaceutical organizations for the purposes of therapeutic drug monitoring programs. Therefore, the robust increase in drug discovery activities being undertaken by several pharma players, and the growing awareness levels concerning the early diagnosis of chronic diseases are also factors that are slated to have a profound influence on the future market growth of this global industry.

In light of the recent COVID-19 outbreak, the operations of numerous industries have been either temporarily halted or are functioning with a minimal workforce due to enforced lockdowns and imposed restrictions by respective governing bodies. Market players in the global chemiluminescence immunoassay industry however, have been more focused on the development and launch of technologically advanced chemiluminescence immunoassay solutions that are capable of offering an accurate diagnosis of COVID-19. This is another factor that is anticipated to compliment the revenue growth of the global chemiluminescence immunoassay market in the foreseeable future.

However, a factor that is expected to potentially impact the revenue growth of the global chemiluminescence immunoassay industry in a negative manner is the high setup costs associated with chemiluminescence immunoassay technique.

Nonetheless, there are several advantages to the use of chemiluminescence immunoassay techniques over other conventional techniques such as RIA and ELISA. This is anticipated to positively impact the revenue growth of the global chemiluminescence immunoassay market in the years to come.

Segmentation of the global chemiluminescence immunoassay market is as follows:

In terms of product, the consumables segment accounted for the maximum number of revenue shares of the global chemiluminescence immunoassay market in 2020, and is expected to continue to do so over the next decade. The instruments segment is slated to index a considerable rate of revenue growth over the forecast period.

On the basis of application, the infectious disease segment accounted for the highest number of revenue shares of the global chemiluminescence immunoassay market in 2020. However, the oncology segment accounted for the highest number of revenue shares of the global chemiluminescence immunoassay industry over the forecast period. This can be attributed to the increasing prevalence of cancer across the world.

With regards to end-use, the hospitals segment accounted for the highest number of revenue shares of the global chemiluminescence immunoassay market in 2020, and is expected to continue to do so in the years to come. The clinical laboratories segment is also slated to index considerable revenue growth in the coming years.

Regional Segmentation and Analysis:

North America accounted for the highest number of revenue shares of the global chemiluminescence immunoassay market in 2020, and is expected to continue to do so over the forecast period. This can be attributed to the presence of well-established healthcare infrastructure the growing prevalence of chronic diseases, as well as the high adoption rates of innovative chemiluminescence immunoassay solutions in this region. However, the markets in the Asia Pacific region are anticipated to register the fastest CAGR over the next decade.

LIAISON® , BioMAP®, IMMULITE®, Atellica®, BIO-FLASH®, QUANTA Flash®, VITROS®, are the brands covered in this Chemiluminescence Immunoassay report.

Below are the active patents related to Chemiluminescence Immunoassay Market.

Patent Number: CN105203746A

POCT (Point of Care Testing) chemiluminescence immunoassay system and method

Abstract

The invention relates to a POCT (Point of Care Testing) chemiluminescence immunoassay system and a POCT chemiluminescence immunoassay method. The POCT chemiluminescence immunoassay system comprises a testing card, an integrated fluid driving module, a magnet control module, a temperature control module, an optical signal detection module, an automatic testing card pushing device and a circuit analysis control module. Whole blood can be adopted as a detection sample of the system, and can be directly used without centrifugal treatment after being sampled, POCT is achieved beside a patient, and a diagnosis result is quickly obtained.

Type: Grant

Filed: 2015-10-26

Date of Patent: 2015-12-30

Inventor: Jiang Runhua Li Quan

Patent Number: US20110111438A1

Method and device for immunoassay

Abstract

The present invention relates to a method and a device for determining a concentration of a biological active substance in a sample by the means of an enzyme-linked immunosorbent assay (ELISA). The device comprises a solid support within a tubing (17) for binding an immunosorbent and an inlet (18, 19) for fluids, a detector (15) for detecting radiation due to an activity in said tubing (17), wherein said tubing (17) is arranged inside a microchip (10) extending substantially in one plane, for conducting the fluids along the plane of the microchip (10). Said tubing (17) forms a reaction cell having a large detection area (22). The reaction cell of the microchip (10) is arranged perpendicular to the detector (15).
The method comprises the steps of introducing the fluids into the tubing (17), conducting the fluids through the tubing (17) forming a reaction cell, in which reaction cell the radiation emitting activity takes place, and detecting the light emitted from the reaction cell substantially perpendicular to the plane.

Type: Grant

Filed: 2010-05-03

Date of Patent: 2011-05-12

Assignee : Prolight Diagnostics AB

Patent Number: US9139766B2

Chemiluminescent compositions and enhancing reagents for chemiluminescence

Abstract

An enhancing reagent for enhancing chemiluminescence of 1,2-dioxetane compounds and a method for using the enhancing reagent to enhance the chemiluminescence are provided, in which the enhancing reagent contains an alkyl bis-quaternary ammonium salt of Formula I. A chemiluminescent composition with a 1,2-dioxetane compound as a substrate and a kit thereof are further provided, which contain a 1,2-dioxetane compound and an alkyl bis-quaternary ammonium salt of Formula I.

Type: Grant

Filed: 2013-10-10

Date of Patent: 2015-09-22

Assignee : Shenzhen Mindray Bio Medical Electronics Co Ltd

Below are the leading companies profiled in this Chemiluminescence Immunoassay Market Report:

  
Abbott Laboratories (US)
  
Autobio (China)
  
Beckman Coulter Inc. (Danaher Corporation Company)
  
Beckman Coulter Inc. (US)
  
Danaher (Beckman Coulter Inc.)
  
DiaSorin SpA (Italy)
  
F. Hoffmann-La Roche Ltd (Switzerland)
  
Fujirebio (Japan)
  
Hoffmann-La Roche AG
  
Immunodiagnostic Systems Holdings Plc
  
Inova Diagnostics, Inc.
  
Maccura Biotechnology Co., Ltd.
  
Mindray (China)
  
Ortho Clinical Diagnostics (Part of Carlyle Group).
  
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  
Shenzhen New Industries Biomedical Engineering Co.Ltd (China)
  
Siemens Healthcare GmbH (Siemens AG)
  
Tosoh Corporation (Japan)

Segmentation of the Global Chemiluminescence Immunoassay Market:

By Product Type

  
Instruments
  
Automated
  
Semi-automated
  
Consumables
  
Software & Services

By Application

  
Therapeutic Drug Monitoring
  
Oncology
  
Cardiology
  
Endocrinology
  
Infectious Disease
  
Autoimmune Disease
  
Others

By End-User

  
Hospitals
  
Clinical Laboratories
  
Pharmaceutical & Biotechnology Companies
  
Others
This research comprehensively answers the following 9 important questions:

  
Q.1. What are some of the most promising growth trends in the Chemiluminescence Immunoassay market worldwide?
  
Q.2.Which segments and sub-segments will grow at a faster pace and why? Which segment is nearing the peak and demand saturation?
  
Q.3.Which region will witness a higher growth rate and why? Which region might see a slower or negative growth region?
  
Q.4.What are the key factors affecting market dynamics? What are the drivers, challenges, and business risks in Chemiluminescence Immunoassay market?
  
Q.5.What are the business risks and who pose challenges to the global leaders and are competitive threats in this Chemiluminescence Immunoassay market?
  
Q.6.What are the emerging trends post COVID-19 reshuffle in this Chemiluminescence Immunoassay market and the what are reasons behind these trends and do they translate in global exploration?
  
Q.7. Who are the major global and regional players in the Chemiluminescence Immunoassay market? Which are the strategic initiatives key players are pursuing for business growth?
  
Q.8.Which are the competing products in Chemiluminescence Immunoassay market and how big of a threat do they pose for loss of market share by material or product substitution?
  
Q.9.What M & A activity has occurred in the last 5 years and what is its impact on the Chemiluminescence Immunoassay industry?